Recent Finacing
Recent Raise
Sprint Bioscience is a Stockholm-based oncology drug-discovery firm using a fragment-based platform—protein expression, fragment screening, high-throughput X-ray crystallography and synthetic chemistry—to generate lead series and provide services to pharma.
